Literature DB >> 20206064

[Epidemiology of chronic obstructive pulmonary disease in France].

C Fuhrman1, M-C Delmas.   

Abstract

This paper aims to summarize the most recent data on the descriptive epidemiology of chronic obstructive pulmonary disease (COPD) in France. Data are presented concerning the prevalence, mortality and hospital admissions. The prevalence of COPD is difficult to estimate due to the large degree of under-diagnosis and the difficulty of performing spirometry in population-based epidemiological surveys. The prevalence of chronic bronchitis was estimated at 4%, and the prevalence of COPD was estimated at 5-10%, among adults aged 45 years and older. Data from death certificates, although limited by the accuracy of certification, showed that the annual age-standardised mortality rates from COPD increased between 1979 and 2000 among women but remained stable among men. In 2006, about 16,500 death certificates mentioned COPD, of which 7400 identified it as the underlying cause of death. According to the French national hospital discharge database, the number of admissions related to an exacerbation of COPD ranged from 69,000 to 112,000 in 2006 according to the definition used. The admission rates have increased between 1998 and 2006 and this increase was more pronounced among women than among men. Large regional differences in COPD mortality and hospital admission rates were evident, with the highest rates in Northern and Eastern France and in Brittany. Copyright 2009 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20206064     DOI: 10.1016/j.rmr.2009.08.003

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  6 in total

1.  A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China.

Authors:  Jiangyu Cui; Yumin Zhou; Jia Tian; Xinwang Wang; Jingping Zheng; Nanshan Zhong; Pixin Ran
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

2.  Trends in use and impact on outcome of empiric antibiotic therapy and non-invasive ventilation in COPD patients with acute exacerbation.

Authors:  Islem Ouanes; Lamia Ouanes-Besbes; Saoussen Ben Abdallah; Fahmi Dachraoui; Fekri Abroug
Journal:  Ann Intensive Care       Date:  2015-10-01       Impact factor: 6.925

3.  Feasibility of spirometry in primary care to screen for COPD: a pilot study.

Authors:  Violaine Giraud; Alain Beauchet; Thierry Gomis; Thierry Chinet
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-12

4.  Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.

Authors:  Benjamin Cadier; Isabelle Durand-Zaleski; Daniel Thomas; Karine Chevreul
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

5.  Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model.

Authors:  Arnaud Cavailles; Boris Melloni; Stéphane Motola; Florent Dayde; Marie Laurent; Katell Le Lay; Didier Caumette; Laura Luciani; Pierre Louis Lleu; Geoffrey Berthon; Thomas Flament
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-30

6.  Gaining a better understanding of respiratory health inequalities among cities: an ecological case study on elderly males in the larger French cities.

Authors:  Christina Aschan-Leygonie; Sophie Baudet-Michel; Hélène Mathian; Lena Sanders
Journal:  Int J Health Geogr       Date:  2013-04-10       Impact factor: 3.918

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.